Articles

Original Research

10.4244/EIJ-D-23-00512 Jan 15, 2024
Clinical characteristics and outcomes of patients requiring prolonged mechanical circulatory support after high-risk percutaneous coronary intervention
Min S, Basir MB, Lemor A, Zhou Z, Abu-Much A, Redfors B, Thompson JB, Truesdell AG, Bharadwaj AS, Li Y, Kaki A, Brott BC, Wohns DH, Meraj PM, Daggubati R, Grines CL, O'Neill WW, Moses J
open access

Original Research

10.4244/EIJ-D-23-00722 Jan 15, 2024
Impact of transcatheter heart valve type on outcomes of surgical explantation after failed transcatheter aortic valve replacement: the EXPLANT-TAVR international registry
Zaid S, Kleiman N, Goel SS, Szerlip MI, Mack MJ, Marin-Cuartas M, Mohammadi S, Nazif TM, Unbehaun A, Andreas M, Brinster DR, Robinson NB, Wang L, Ramlawi B, Conradi L, Desai N, Forrest JK, Bagur R, Nguyen TC, Waksman R, Leroux L, Van Belle E, Grubb KJ, Ahmad H, Denti P, Modine T, Bapat VN, Kaneko T, Reardon MJ, Tang GH, EXPLANT-TAVR registry investigators obot
free

Original Research

10.4244/EIJ-D-23-00469 Jan 15, 2024
Contemporary guideline-directed management of patients with severe aortic valve stenosis
Wang X, Arslani K, Nuyens P, Montarello N, Vanhaverbeke M, Bieliauskas G, Sondergaard L, De Backer O
free

Editorial

Jan 1, 2024
EuroIntervention: the dawn of a new era
Capodanno D
free

Editorial

10.4244/EIJ-E-23-00062 Jan 1, 2024
Hybrid coronary revascularisation: the best or the worst of both worlds?
Gaudino M, Sandner S
free

Editorial

10.4244/EIJ-E-23-00064 Jan 1, 2024
Robotic-assisted percutaneous coronary intervention: the future or the past?
Durand E, Eltchaninoff H
free

Editorial

10.4244/EIJ-E-23-00056 Jan 1, 2024
The first cut is the deepest – a solution for treating calcified lesions?
Mashayekhi K, Moos S
free

Editorial

10.4244/EIJ-E-23-00058 Jan 1, 2024
Real-world evidence with the ACURATE neo2: a prelude to the ACURATE IDE trial
Windecker S, Tomii D
free

Debate

10.4244/EIJ-E-23-00023 Jan 1, 2024
Observational studies play little role in guiding evidence-based medicine: pros and cons
Steg P, Feldman L, Omerovic E
free

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R, Merdler I, Case BC, Waksman O, Porto I
free
Receive our newsletter


PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved